Michael Sergeevich Zastrozhin (Mikhail Sergeevich Zastrozhin, Michael S Zastrozhin, M S Zastrozhin)

ResearcherID ResearcherID Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 6

Top Topics

Prognostic Factors

Pain Management

Ejection Fraction

Alcohol Use Disorder

Top Venues

Drug metabolism and personalized therapy

Pharmacogenomics

Human psychopharmacology

Terapevticheskii arkhiv

This page only lists publications with an associated author ORCID identifier.

Publications

Dmitry Alekseevich Sychev, A I Parusov, I D Loranskaya, Natalia P Denisenko, Kristina Anatolyevna Akmalova, Zhannet Alimovna Sozaeva, O L Turkina, Michael Sergeevich Zastrozhin
[CYP2D6 gene polymorphic markers role in determining the optimal treatment tactics for portal hypertension in patients with liver cirrhosis]. Terapevticheskii arkhiv 94 (2) (2022)
Andranik Alexandrovich Muradian, Dmitry Alekseevich Sychev, Dmitry Alekseevich Blagovestnov, Zhannet Alimovna Sozaeva, Kristina Anatolyevna Akmalova, Michael Sergeevich Zastrozhin, Leyla Nabievna Kerimova, Vadim Teymurazovich Koroshvili, Irina Alexandrovna Epifanova
The effect of CYP2D6 and CYP2C9 gene polymorphisms on the efficacy and safety of the combination of tramadol and ketorolac used for postoperative pain management in patients after video laparoscopic cholecystectomy. Drug metabolism and personalized therapy (2021)
Andranik Alexandrovich Muradian, Dmitry Alekseevich Sychev, Dmitry Alekseevich Blagovestnov, Zhannet Alimovna Sozaeva, Kristina Anatolyevna Akmalova, Michael Sergeevich Zastrozhin, Leyla Nabievna Kerimova, Vadim Teymurazovich Koroshvili, Irina Alexandrovna Epifanova
The effect of CYP2D6 and CYP2C9 gene polymorphisms on the efficacy and safety of the combination of tramadol and ketorolac used for postoperative pain management in patients after video laparoscopic cholecystectomy. Drug metabolism and personalized therapy 37 (1) (2021)
Michael Sergeevich Zastrozhin, Valentin Y Skryabin, Marco Torrado, Anastasiya Petrovna, Alexander S Sorokin, Elena A Grishina, Kristina A Ryzhikova, Inessa A Bedina, Oleg Z Buzik, Egor M Chumakov, Ludmila M Savchenko, Evgeny A Brun, Dmitry A Sychev
Effects of CYP2C19*2 polymorphisms on the efficacy and safety of phenazepam in patients with anxiety disorder and comorbid alcohol use disorder. Pharmacogenomics 21 (2) (2020)
Michael Sergeevich Zastrozhin, Valentin Yurievich Skryabin, Alexander Sergeevich Sorokin, Aleksey Evgenievich Petukhov, Valery Valerievich Smirnov, Ekaterina Petrovna Pankratenko, Elena Anatolievna Grishina, Kristina Anatolievna Ryzhikova, Aleksey Sergeevich Panov, Ludmila Mikhailovna Savchenko, Evgeny Alekseevich Bryun, Dmitry Alekseevich Sychev
CYP3A subfamily activity affects the equilibrium concentration of Phenazepam® in patients with anxiety disorders and comorbid alcohol use disorder. Pharmacogenomics 21 (7) (2020)
Michael Sergeevich Zastrozhin, Aleksandr S Sorokin, Tatyana V Agibalova, Elena A Grishina, Anastasiya P Antonenko, Ilya N Rozochkin, Denis O Lamoureux, Valentin Yurievich Skryabin, Tatyana E Galaktionova, Ilya V Barna, Anna V Orlova, Albert D Aguzarov, Ludmila M Savchenko, Evgeny A Bryun, Dmitry Alekseevich Sychev
Using a personalized clinical decision support system for bromdihydrochlorphenylbenzodiazepine dosing in patients with anxiety disorders based on the pharmacogenomic markers. Human psychopharmacology 33 (6) (2018)